Breaking News Instant updates and real-time market news.

2021-03-02 14:06:45 DIN Dine Brands $79.00 / -2.625 (-3.22%) 14:06 03/02/21 03/02 14:06 03/02/21 14:06	Dine Brands says Applebee's SSS improving roughly 8% QTD from January Says IHOP SSS improving roughly 6% quarter-to-date from January. Says overall weekly sales trends for both brands improving since week ending January 3. Says "certainly optimistic" about Applebee's and IHOP during "times of crisis." Guidance taken from Q4 earnings conference call.	02 Mar
DIN Dine Brands $79.00 / -2.625 (-3.22%) 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James

2021-03-02 14:06:45

DIN

Dine Brands

$79.00 / -2.625 (-3.22%)

14:06

03/02/21

03/02

14:06

03/02/21

14:06

Dine Brands says Applebee's SSS improving roughly 8% QTD from January

Says IHOP SSS improving roughly 6% quarter-to-date from January. Says overall weekly sales trends for both brands improving since week ending January 3. Says "certainly optimistic" about Applebee's and IHOP during "times of crisis." Guidance taken from Q4 earnings conference call.

02
Mar

DIN Dine Brands

$79.00 / -2.625 (-3.22%)

02/10/21 Deutsche Bank: Dine Brands downgraded to Hold from Buy at Deutsche Bank

01/20/21 Wedbush: Dine Brands added to Best List Ideas, target raised to $83 at Wedbush

01/06/21 Raymond James: Dine Brands upgraded to Outperform from Market Perform at Raymond James

01/06/21 Raymond James: Dine Brands upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Hot Stocks	Genetic Technologies appoints Mike Tonroe as CFO » 08:17 04/12/21 04/12 08:17 04/12/21 08:17 GENE Genetic Technologies $4.54 / +0.26 (+6.07%) , OPT Opthea $9.68 / -0.32 (-3.20%) Genetic Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options GENE OPT GENE Genetic Technologies $4.54 / +0.26 (+6.07%) 03/04/21 Genetic Technologies signs multi-year distribution agreement for COVID Risk Test 03/01/21 Genetic Technologies trading halted, news pending 01/21/21 Genetic Technologies provides update on COVID-19 disease severity risk test 12/02/20 Genetic Technologies secures U.S., Australia distribution rights for Predictix OPT Opthea $9.68 / -0.32 (-3.20%) 04/06/21 Opthea CFO Michael Tonroe to resign 03/31/21 Opthea receives iPSP waiver from FDA for OPT-302 03/15/21 Opthea announces first patient treated in OPT-302 clinical program 02/24/21 Opthea finalizes design for ShORe, COAST clinical trials of OPT-302 GENE OPT GENE Genetic Technologies $4.54 / +0.26 (+6.07%) OPT Opthea $9.68 / -0.32 (-3.20%) 11/17/20 Citi Opthea initiated with a Buy at Citi 11/11/20 SVB Leerink SVB Leerink bullish on Opthea, initiates with an Outperform 11/11/20 SVB Leerink Opthea initiated with an Outperform at SVB Leerink 11/11/20 Oppenheimer Opthea initiated with an Outperform at Oppenheimer 16 Oct GENE GENE Genetic Technologies $4.54 / +0.26 (+6.07%) 03/12/21 Study validates Genetic Tech's clinical model for predicting risk, medRxiv says OPT OPT Opthea $9.68 / -0.32 (-3.20%) 10/18/20 Opening Day: Array jumps after $1.05B IPO GENE GENE Genetic Technologies $4.54 / +0.26 (+6.07%) 01/05/21 Largest borrow rate increases among liquid names 12/23/20 Largest borrow rate increases among liquid names
Hot Stocks	Catalyst Biosciences expands protease medicines patent portfolio » 08:15 04/12/21 04/12 08:15 04/12/21 08:15 CBIO Catalyst Biosciences $5.10 / -0.06 (-1.16%) Catalyst Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CBIO Catalyst Biosciences $5.10 / -0.06 (-1.16%) 03/04/21 Catalyst Biosciences announces expected near-term milestones 02/03/21 Catalyst Biosciences presents SQ treatement of bleeds data 12/07/20 Catalyst Biosciences presents Crimson 1 Phase 3 study design 12/02/20 Catalyst Biosciences receives FDA fast track designation for MarzAA CBIO Catalyst Biosciences $5.10 / -0.06 (-1.16%) 03/04/21 Piper Sandler Catalyst Biosciences' momentum to build throughout 2021, says Piper Sandler 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Piper Sandler Catalyst Biosciences initiated with an Overweight at Piper Sandler 02/09/21 JonesTrading Catalyst Biosciences assumed with a Buy at JonesTrading CBIO Catalyst Biosciences $5.10 / -0.06 (-1.16%) 03/04/21 Catalyst Biosciences reports Q4 EPS (86c), consensus (86c) 11/05/20 Catalyst Biosciences reports Q3 EPS (73c), consenus (81c) 27 Jan 18 Jun 04/20/21 FuboTV
Hot Stocks	Twist Bioscience exercises option to purchase GPCR library » 08:15 04/12/21 04/12 08:15 04/12/21 08:15 TWST Twist Bioscience $132.60 / +0.48 (+0.36%) Twist Bioscience… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events TWST Twist Bioscience $132.60 / +0.48 (+0.36%) 04/07/21 Twist Bioscience to provide antibody discovery, for drug research to Stanford 03/25/21 Twist Bioscience and Kyowa Kirin partner for GPCR antibody discovery 03/24/21 Twist Bioscience , Biota get FDA EUA for SARS-CoV-2 NGS assay 03/22/21 Twist Bioscience releases preclinical data on GLP-1R antibodies TWST Twist Bioscience $132.60 / +0.48 (+0.36%) 04:54 Today Piper Sandler Twist Bioscience initiated with an Overweight at Piper Sandler 02/05/21 Baird Twist Bioscience price target raised to $200 from $125 at Baird 02/05/21 JPMorgan Twist Bioscience downgraded to Underweight from Neutral at JPMorgan 01/04/21 Evercore ISI Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time TWST Twist Bioscience $132.60 / +0.48 (+0.36%) 02/04/21 Twist Bioscience backs FY21 revenue view $110M-$118M, consensus $116.02M 02/04/21 Twist Bioscience reports Q1 EPS (72c), consensus (74c) 11/23/20 Twist Bioscience sees Q1 revenue $25M-$26M 11/23/20 Twist Bioscience sees FY21 revenue $110M-$118M, consensus $117.9M 03 Dec 04 Jun TWST Twist Bioscience $132.60 / +0.48 (+0.36%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021
Hot Stocks	MarketAxess completes acquisition of MuniBrokers » 08:14 04/12/21 04/12 08:14 04/12/21 08:14 MKTX MarketAxess $534.38 / +3.83 (+0.72%) MarketAxess Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MKTX MarketAxess $534.38 / +3.83 (+0.72%) 03/02/21 MarketAxess announces February trading volume $610.4B 02/02/21 MarketAxess reports January monthly trading volume $575.3B 01/27/21 MarketAxess announces new $100M share repurchase plan 01/27/21 MarketAxess sees FY21 CapEx $50M-$55M MKTX MarketAxess $534.38 / +3.83 (+0.72%) 04/09/21 Deutsche Bank MarketAxess price target lowered to $558 from $570 at Deutsche Bank 04/06/21 Piper Sandler MarketAxess price target lowered to $545 from $580 at Piper Sandler 03/02/21 Morgan Stanley Tradeweb Markets resumed with an Overweight at Morgan Stanley 02/03/21 MarketAxess price target raised to $670 from $605 at Rosenblatt MKTX MarketAxess $534.38 / +3.83 (+0.72%) 01/27/21 MarketAxess reports Q4 EPS $1.91, consensus $1.83 10/27/20 MarketAxess reports Q3 EPS $1.78, consensus $1.74 04/22/21 MarketAxess - MKTX
Hot Stocks	NuGenerex submits protocol, data, manufacturing information to FDA » 08:14 04/12/21 04/12 08:14 04/12/21 08:14 GNBT Generex / + NuGenerex Immuno-Oncology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News GNBT Generex / + 02/24/21 Generex, NuGenerex provide update on COVID-19 vaccine development program 12/31/20 Generex, NuGenerex provide update on COVID-19 vaccine development program 11/23/20 Generex partner Bintai Kinden executes distribution, licensing option 11/19/20 Generex signs licensing deal with China partners on vaccine development

Hot Stocks	IBM's Independent Managed Infrastructure Services business to be named Kyndryl » 08:13 04/12/21 04/12 08:13 04/12/21 08:13 IBM IBM $135.73 / +0.58 (+0.43%) IBM announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM IBM $135.73 / +0.58 (+0.43%) 04/08/21 Qualtrics announces new partnership with IBM Japan 04/01/21 Celonis, IBM and Red Hat announce business execution partnership 03/30/21 IBM, Cleveland Clinic announce 10-year partnership to accelerate discovery 03/28/21 Fly Intel: Top five weekend stock stories IBM IBM $135.73 / +0.58 (+0.43%) 04/08/21 Morgan Stanley IBM price target raised to $150 from $140 at Morgan Stanley 03/24/21 Evercore ISI Intel price target raised to $75 from $68 at Evercore ISI 03/23/21 KeyBanc Box price target raised to $27 from $22 at KeyBanc 03/12/21 JMP Securities Domo price target raised to $89 from $80 at JMP Securities IBM IBM $135.73 / +0.58 (+0.43%) 01/21/21 IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5% 01/21/21 IBM reports Q4 adjusted EPS $2.07, consensus $1.79 01/21/21 Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% IBM IBM $135.73 / +0.58 (+0.43%) 03/27/21 Verizon, IBM among stocks to build income stream for long haul, Barron's says 02/18/21 IBM considering sale of IBM Watson Health, WSJ reports 02/18/21 IBM considering sale of IBM Watson Health, WSJ reports 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports IBM IBM $135.73 / +0.58 (+0.43%) 03/24/21 Street Fight: Analysts diverge on Intel following 'Unleashed' event 02/08/21 Fly Intel: Wall Street's top stories for Monday 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Technology, Media & Communications Virtual Conference 04/27/21 International Business Machines Corp. IBM IBM $135.73 / +0.58 (+0.43%) 03/18/21 IBM call volume above normal and directionally bullish 03/01/21 IBM call volume above normal and directionally bullish 01/21/21 IBM options imply 6.3% move in share price post-earnings 01/05/21 Unusually active option classes on open January 5th
Upgrade	Match Group upgraded to Buy at BTIG given pullback in stock price » 08:13 04/12/21 04/12 08:13 04/12/21 08:13 MTCH Match Group $143.97 / -1.68 (-1.15%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options MTCH Match Group $143.97 / -1.68 (-1.15%) 03/15/21 Match Group partners with Garbo on background checks 02/16/21 PLBY Group appoints Lance Barton as CFO 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock MTCH Match Group $143.97 / -1.68 (-1.15%) 06:52 Today BTIG Match Group upgraded to Buy from Neutral at BTIG 04/05/21 Evercore ISI Match Group assumed with an Outperform at Evercore ISI 03/11/21 Morgan Stanley Bumble report featured 'no big surprises,' says Morgan Stanley 03/08/21 JPMorgan Bumble initiated with a Neutral at JPMorgan MTCH Match Group $143.97 / -1.68 (-1.15%) 02/02/21 Match Group sees Q1 revenue of $645M-$655M, consensus $646.6M 02/02/21 Match Group sees FY21 revenue $2.75B-$2.85B, consensus $2.84B 02/02/21 Match Group reports Q4 EPS 48c, consensus 49c 02/02/21 Notable companies reporting after market close MTCH Match Group $143.97 / -1.68 (-1.15%) 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 03/08/21 Bumble stock under pressure as Wall Street rolls out coverage 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday MTCH Match Group $143.97 / -1.68 (-1.15%) 02/02/21 Match Group options imply 12.4% move in share price post-earnings 11/17/20 Unusual put flow in option market yesterday 11/16/20 Match Group put seller looking for 11-day $300k fling
Hot Stocks	Sterling Bancorp signs banking as a service agreement with BrightFi » 08:13 04/12/21 04/12 08:13 04/12/21 08:13 STL Sterling Bancorp $23.19 / +0.11 (+0.48%) Sterling National Bank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STL Sterling Bancorp $23.19 / +0.11 (+0.48%) 04/05/21 Sterling National Bank signs agreement with Rho Technologies 03/22/21 First Northwest Bancorp to purchase Bellevue, WA branch from Sterling Bank 02/24/21 Sterling National Bank collaborates with Google Pay 01/11/21 Sterling Bancorp appoints Luis Massiani as COO, Bea Ordonez as CFO STL Sterling Bancorp $23.19 / +0.11 (+0.48%) 01/25/21 B. Riley Securities Sterling Bancorp pullkback brings 'unique' buying opportunity, says B. Riley 01/07/21 B. Riley Securities Sterling Bancorp price target raised to $25 from $21 at B. Riley Securities 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global Sterling Bancorp initiated with a Buy at Seaport Global STL Sterling Bancorp $23.19 / +0.11 (+0.48%) 01/20/21 Sterling Bancorp reports Q4 EPS 49c, consensus 46c 01/20/21 Notable companies reporting after market close 10/21/20 Sterling Bancorp reports Q3 EPS 43c, consensus 39c 10/21/20 Notable companies reporting after market close
Upgrade	Evercore upgrades laggard Kilroy to Outperform amid signs of leasing interest » 08:12 04/12/21 04/12 08:12 04/12/21 08:12 KRC Kilroy Realty $66.71 / +0.08 (+0.12%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events KRC Kilroy Realty $66.71 / +0.08 (+0.12%) 03/08/21 Kilroy Realty to sell The Exchange in San Francisco's Mission Bay for $1.08B 12/30/20 Kilroy Realty promotes Michelle Ngo to role of CFO, Tyler Rose to President KRC Kilroy Realty $66.71 / +0.08 (+0.12%) 05:38 Today Evercore ISI Kilroy Realty upgraded to Outperform from In Line at Evercore ISI 04/05/21 BMO Capital Kilroy Realty price target raised to $79 from $75 at BMO Capital 03/09/21 BMO Capital Kilroy Realty price target raised to $75 from $69 at BMO Capital 03/08/21 BMO Capital Kilroy Realty price target raised to $75 from $69 at BMO Capital KRC Kilroy Realty $66.71 / +0.08 (+0.12%) 02/01/21 Kilroy Realty reports Q4 FFO 95c with items, consensus 97c 10/28/20 Kilroy Realty reports Q3 FFO 99c, consensus 95c 04/29/21 Kilroy Realty - KRC
Hot Stocks	Bally's announces agreement with Sinclair Broadcast » 08:12 04/12/21 04/12 08:12 04/12/21 08:12 BALY Bally's $61.69 / -0.315 (-0.51%) , SBGI Sinclair Broadcast $29.85 / -0.3 (-1.00%) Bally's (BALY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BALY SBGI BALY Bally's $61.69 / -0.315 (-0.51%) 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's 03/25/21 Bally's Richmond Casino Resort selected as one of three finalists in Virginia 03/24/21 Bally's reports agreement in principle to buy Gamesys Group plc 03/22/21 Allied Esports, Element Partners report revised stock purchase agreement SBGI Sinclair Broadcast $29.85 / -0.3 (-1.00%) 01/26/21 Sinclair Broadcast names Jeffrey Lewis as chief compliance officer 11/19/20 Bally's, Sinclair announce 10-year sports betting and iGaming partnership 11/04/20 Sinclair Broadcast CEO says Q3 results 'exceeded our expectations' 11/04/20 Sinclair Broadcast reports Q3 consolidated adjusted EBITDA $736M, up 97% y/y BALY SBGI BALY Bally's $61.69 / -0.315 (-0.51%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies SBGI Sinclair Broadcast $29.85 / -0.3 (-1.00%) 12/22/20 Deutsche Bank Sinclair Broadcast resumed with a Hold at Deutsche Bank 12/17/20 Fly Intel: Top five analyst upgrades 12/17/20 Wells Fargo Sinclair Broadcast upgraded to Equal Weight from Underweight at Wells Fargo 11/20/20 Benchmark Sinclair Broadcast price target raised to $35 from $28 at Benchmark BALY SBGI BALY Bally's $61.69 / -0.315 (-0.51%) 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings SBGI Sinclair Broadcast $29.85 / -0.3 (-1.00%) 02/24/21 Sinclair Broadcast sees Q1 revenue $1.46B-$1.49B, consensus $1.52B 02/24/21 Sinclair Broadcast reports Q4 EPS $6.27, consensus $5.01 11/04/20 Sinclair Broadcast sees Q4 revenue $1.49B-$1.52B, consensus $1.64B 11/04/20 Sinclair Broadcast reports Q3 EPS ($42.66) vs. (64c) a year ago BALY BALY Bally's $61.69 / -0.315 (-0.51%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY SBGI BALY Bally's $61.69 / -0.315 (-0.51%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday SBGI Sinclair Broadcast $29.85 / -0.3 (-1.00%) 04/01/21 Bet On It: Sports betting operators make more content-related deals 01/29/21 Bet On It: Collaboration fuels sports betting nationwide 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 11/20/20 Bet On It: Ohio and Massachusetts look to establish sports betting market 05/24/21 Global Technology, Media & Communications Virtual Conference 05/18/21 Bally's Corporation

Hot Stocks	CNH Industrial's IVECO signs MOU with Plus to develop autonomous trucks » 08:12 04/12/21 04/12 08:12 04/12/21 08:12 CNHI CNH Industrial $15.62 / -0.225 (-1.42%) IVECO announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNHI CNH Industrial $15.62 / -0.225 (-1.42%) 03/26/21 CNH Industrial acquires minority stake in Bennamann 03/24/21 EU commercial vehicle registrations up 1.2% in February 03/23/21 CNH Industrial acquires minority stake in Augmenta, terms not disclosed 03/02/21 CNH Industrial completes minority investment in Monarch Tractor CNHI CNH Industrial $15.62 / -0.225 (-1.42%) 02/18/21 Citi CNH Industrial resumed with a Buy at Citi 02/04/21 Vertical Research CNH Industrial upgraded to Buy from Hold at Vertical Research 01/20/21 Vertical Research CNH Industrial initiated with a Hold at Vertical Research 12/15/20 Stifel CNH Industrial price target raised to $12 from $9.50 at Stifel CNHI CNH Industrial $15.62 / -0.225 (-1.42%) 02/03/21 CNH Industrial reports Q4 adjusted EPS 30c, consensus 14c 11/05/20 CNH Industrial reports Q3 adjusted EPS 11c, consensus 2c
Hot Stocks	Rubius Therapeutics announces first patient dosed in phase 1 trial of RTX-321 » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) Rubius Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 04/09/21 Rubius Therapeutics to present initial results from Phase 1/2 trial of RTX-240 03/15/21 Rubius Therapeutics trading resumes 03/15/21 Rubius Therapeutics soars 65% to $27.05 after solid tumor trial data 03/15/21 Rubius Therapeutics trading halted, volatility trading pause RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 03/15/21 H.C. Wainwright Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright 10/14/20 JPMorgan Rubius Therapeutics resumed with a Neutral at JPMorgan RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 02/23/21 Rubius Therapeutics reports Q4 EPS (50c), consensus (49c) 11/09/20 Rubius Therapeutics reports Q3 EPS (51c), consensus (49c) 17 Mar RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 03/17/21 Fly Intel: Wall Street's top stories for Wednesday 03/17/21 Fly Intel: Wall Street's top stories at midday 03/15/21 Fly Intel: Wall Street's top stories for Monday 03/15/21 Fly Intel: Wall Street's top stories at midday 05/12/21 Rubius Therapeutics, Inc
Hot Stocks	Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 TMO Thermo Fisher $478.87 / +7.3 (+1.55%) Thermo Fisher Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts 03/24/21 Thermo Fisher announces launch of in-air SARS-CoV-2 surveillance solution 03/10/21 Thermo Fisher investing over $600M to expand bioprocessing production 03/08/21 Chembio Diagnostics appoints David Bespalko to board of directors TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Thermo Fisher initiated with an Overweight at Barclays TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/29/21 Thermo Fisher - TMO 05/19/21 Thermo Fisher Scientific Inc.
Hot Stocks	Tattooed Chef launches new plant-based pizzas » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) Tattooed Chef announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Tattooed Chef launches six plant-based products at Target stores 01/14/21 Tattooed Chef announces redemption of public warrants 12/08/20 Tattooed Chef expands product range with meal alternatives TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 12/03/20 Jefferies Tattooed Chef initiated with a Hold at Jefferies 11/17/20 Roth Capital Tattooed Chef initiated with a Buy at Roth Capital TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Tattooed Chef backs FY21 revenue view $222M, consenus $224M 03/10/21 Tattooed Chef reports Q4 EPS 56c, consensus 3c TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 11/20/20 Tattooed Chef tells Bloomberg short report claims 'false' and 'misleading' 11/19/20 Kerrisdale Capital short Tattooed Chef, sees 'investors left holding the bag' 11/19/20 Tattooed Chef named as short by Kerrisdale Capital TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Fly Intel: After-Hours Movers 12/08/20 Fly Intel: After-Hours Movers TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 04/08/21 Tattooed Chef put volume heavy and directionally bearish 03/10/21 Tattooed Chef options imply 16.8% move in share price post-earnings 02/04/21 Largest borrow rate increases among liquid names 02/01/21 Largest borrow rate increases among liquid names
Hot Stocks	Morphic presents preclinical data from avb8 integrin program at AACR meeting » 08:09 04/12/21 04/12 08:09 04/12/21 08:09 MORF Morphic $59.10 / -1.94 (-3.18%) Morphic Therapeutic… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MORF Morphic $59.10 / -1.94 (-3.18%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen MORF Morphic $59.10 / -1.94 (-3.18%) 03/03/21 SVB Leerink Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital MORF Morphic $59.10 / -1.94 (-3.18%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 03 Mar MORF Morphic $59.10 / -1.94 (-3.18%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers

Hot Stocks	Mirum Pharmaceuticals and Vivet in pact for Vivet's gene therapy » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) Mirum Pharmaceuticals and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/29/21 Mirum Pharmaceuticals announces FDA acceptance of maralixibat NDA 03/08/21 Mirum Pharmaceuticals CFO buys 1.6K shares of common stock 02/01/21 Mirum completes rolling NDA submission for maralixibat in Alagille 12/09/20 Mirum Pharmaceuticals, Oberland announce up to $210M funding arrangement MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/29/21 Piper Sandler Piper says Mirum approval for Alagille syndrome 'in the bag' 02/08/21 SVB Leerink Mirum Pharmaceuticals initiated with an Outperform at SVB Leerink 02/01/21 Piper Sandler Piper says FDA 'very unlikely' to require AdCom for Mirum's maralixibat in ALGS 12/09/20 Piper Sandler Mirum Pharmaceuticals investor day highlights pipeline advances, says Piper MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/09/21 Mirum Pharmaceuticals reports Q4 EPS ($1.43), consensus (72c) 11/12/20 Mirum Pharmaceuticals reports Q3 EPS (86c), consensus (97c) 15 Dec MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 12/15/20 Fly Intel: Wall Street's top stories at midday 12/15/20 Fly Intel: Pre-market Movers 09/29/21 PDUFA Date for Maralixibat
Hot Stocks	FLIR Systems awarded up to $20.5M DARPA contract » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 FLIR FLIR Systems $57.69 / + (+0.00%) FLIR Systems announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FLIR FLIR Systems $57.69 / + (+0.00%) 04/01/21 Teledyne clears Canada, Germany antitrust reviews for acquisition of FLIR Systems 01/26/21 FLIR gets $30.1M contract boost from US Army for sustainment efforts on programs 01/13/21 FLIR Systems announces $23M in awards from U.S. CBP 01/04/21 FLIR Systems jumps 22% to $53.75 after agreeing to be acquired by Teledyne FLIR FLIR Systems $57.69 / + (+0.00%) 01/07/21 Berenberg FLIR Systems downgraded to Hold from Buy at Berenberg 01/05/21 Canaccord FLIR Systems downgraded to Hold from Buy at Canaccord 01/05/21 William Blair FLIR Systems downgraded to Market Perform from Outperform at William Blair 01/05/21 Needham Teledyne price target raised to $395 from $365 at Needham FLIR FLIR Systems $57.69 / + (+0.00%) 02/25/21 FLIR Systems reports Q4 EPS 78cc, consensus 62c 10/30/20 FLIR Systems raises FY20 adj. EPS view to $2.30-$2.35 from $2.10-$2.30 10/30/20 FLIR Systems reports Q3 adj. EPS 64c, consensus 55c FLIR FLIR Systems $57.69 / + (+0.00%) 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 01/04/21 Fly Intel: Pre-market Movers FLIR FLIR Systems $57.69 / + (+0.00%) 01/15/21 Largest borrow rate increases among liquid names 01/04/21 Early notable gainers among liquid option names on January 4th
Hot Stocks	Lakeland Financial launches Lack City Bank Digital » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) Lake City Bank announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) 02/11/21 Lakeland Financial director Smith sells over $650K in stock 01/13/21 Lakeland Financial raises quarterly dividend 13% to 34c per share LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) 01/25/21 Lakeland Financial reports Q4 EPS 97c, consensus 80c 10/26/20 Lakeland Financial reports Q3 EPS 89c, consensus 71c 04/13/21 Lakeland Financial Corporation
Hot Stocks	REE Automotive signs collaboration agreement with Magna » 08:07 04/12/21 04/12 08:07 04/12/21 08:07 VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) REE Automotive, an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Options VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 03/15/21 REE Automotive teases announcement coming March 16 02/03/21 10X Capital Venture Acquisition Corporation (Class A Stock) trading resumes 02/03/21 REE Automotive to become public in $3.1B 10X Capital Venture Acquisition merger 02/03/21 10X Capital Venture Acquisition Corporation (Class A Stock) trading halted, news pending VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 11/29/20 Opening Day: Russian online retailer raises $990M in U.S. IPO VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 02/10/21 Seven new option listings and three option delistings on February 10th
Initiation	Sun Country Airlines initiated with an Equal Weight at Morgan Stanley » 08:07 04/12/21 04/12 08:07 04/12/21 08:07 SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate Periodicals On The Fly SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 04/11/21 Goldman Sachs Sun Country Airlines initiated with a Buy at Goldman Sachs 17 Mar SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 03/16/21 Sun Country Airlines to price IPO at $24/shr, above $21-$23 range, Bloomerg says SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO

Hot Stocks	BIO-key announces new fingerprint scanner hardware additions » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 BKYI BIO-key $3.58 / -0.09 (-2.45%) BIO-key International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BKYI BIO-key $3.58 / -0.09 (-2.45%) 04/07/21 BIO-key adds Kristel Communication to Channel Alliance Partner Program 04/05/21 BIO-key announces $1.2M contract extension for fingerprint biometric security 03/31/21 International Defense Ministry continue expansion of BIO-key biometric solutions 03/23/21 BIO-key begins biometric technology deployments for ID projects in Africa BKYI BIO-key $3.58 / -0.09 (-2.45%) 03/26/21 Maxim BIO-key upgraded to Buy from Hold at Maxim 03/26/21 Maxim BIO-key upgraded to Buy from Hold at Maxim BKYI BIO-key $3.58 / -0.09 (-2.45%) 03/25/21 BIO-key sees 2021 revenue $8M-$12M, one est. $7.5M 03/25/21 BIO-key reports Q4 EPS (18c), one est. (16c) 01/27/21 BIO-key's IDaaS platform selected by Southeastern Illinois College 11/12/20 BIO-key reports Q3 EPS (6c), one est. (1c) BKYI BIO-key $3.58 / -0.09 (-2.45%) 02/18/21 Fourteen new option listings and one option delisting on February 18th
Hot Stocks	Jounce Therapeutics appoints Dmitri Wiederschain as Chief Scientific Officer » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) , SNY Sanofi $50.80 / +0.43 (+0.85%) Jounce Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 04/11/21 Jounce Therapeutics presents preclinical data from JTX-8064/LILRB2 Program 02/25/21 Jounce Therapeutics sees cash, cash equivalents sufficient into 2Q23 02/12/21 Jounce Therapeutics appoints Luisa Salter-Cid to board of directors 01/29/21 Adage Capital reports 6.95% passive stake in Jounce Therapeutics SNY Sanofi $50.80 / +0.43 (+0.85%) 07:21 Today C4XD enters licensing agreement with Sanofi for oral IL-17A inhibitor program 04/09/21 Sanofi acquires Tidal Therapeutics for $160M upfront payment 04/09/21 Sanofi says interim late-breaking data validate not-alpha profile of THOR-707 03/31/21 Sanofi announces FDA approved Sarclisa+carfilzomib in RRMM JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 03/14/21 Piper Sandler Jounce Therapeutics initiated with an Overweight at Piper Sandler 02/26/21 H.C. Wainwright Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright 12/04/20 H.C. Wainwright Jounce Therapeutics assumed with a Buy at H.C. Wainwright 11/10/20 Roth Capital Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital SNY Sanofi $50.80 / +0.43 (+0.85%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 02/25/21 Jounce Therapeutics reports Q4 EPS 86c, consensus 22c 11/06/20 Jounce Therapeutics reports Q3 EPS (73c), consensus (47c) SNY Sanofi $50.80 / +0.43 (+0.85%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year 10 Mar SNY SNY Sanofi $50.80 / +0.43 (+0.85%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 03/09/21 Fly Intel: After-Hours Movers SNY Sanofi $50.80 / +0.43 (+0.85%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 04/28/21 Sanofi - SNY 05/18/21 PDUFA Date for Avalglucosidase Alfa
Hot Stocks	Osisko Gold to acquire additional royalties in Nevada, Idaho for $26M » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 OR Osisko Gold $12.11 / +0.065 (+0.54%) Through a subsidiary,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/08/21 Osisko Gold releases ESG report 02/16/21 Osisko Gold receives approval for Canadian Malartic Underground construction 01/20/21 Osisko Gold appoints Candace MacGibbon to board of directors 01/13/21 Osisko Gold appoints Heather Taylor to VP, investor relations OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/06/21 Scotiabank Osisko Gold price target raised to C$28.50 from C$27.50 at Scotiabank 02/26/21 National Bank Osisko Gold price target lowered to C$23 from C$23.50 at National Bank 02/25/21 BMO Capital Osisko Gold price target lowered to C$20 from C$21 at BMO Capital 02/12/21 Scotiabank Osisko Gold price target raised to C$27.50 from C$25 at Scotiabank OR Osisko Gold $12.11 / +0.065 (+0.54%) 08:03 Today Osisko Gold reports Q1 preliminary revenue C$66.9M, one est. C$69.36M 01/13/21 Osisko Gold reports Q4 preliminary revenues C$64.5M 10/20/20 Osisko Gold reports preliminary Q3 revenues C$55.7M, consensus C$59.25M
Hot Stocks	VBI Vaccines announces data, next steps from VBI-2601 high-dose cohort » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) VBI Vaccines announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 03/10/21 CEPI and VBI Vaccines collaborate to advance vaccine candidates against COVID-19 03/09/21 VBI Vaccines begins enrollment of Phase 1/2 clinical study of VBI-2902 03/09/21 VBI Vaccines begins enrollment in prophylactic COVID-19 vaccine candidate 02/02/21 FDA accepts VBI Vaccines BLA filing for its antigen prophylactic Hep B vaccine VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 02/25/21 Jefferies VBI Vaccines initiated with a Buy at Jefferies 08/27/20 Raymond James VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James 08/27/20 Oppenheimer VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer 08/26/20 Raymond James VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 03/02/21 VBI Vaccines reports Q4 revenue $200,000, consensus $410,000 22 Apr VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 02/10/21 Scientists working on shot that could protect against Covid-19, others, NYT says 11/30/21 PDUFA Date for
Hot Stocks	Gemini Therapeutics appoints Samuel Barone, M.D., as Chief Medical Officer » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) Gemini Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 02/10/21 Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103 02/09/21 Gemini Therapeutics appoints Brian Piekos as CFO 02/08/21 Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 04/08/21 SVB Leerink SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform 04/08/21 SVB Leerink Gemini Therapeutics initiated with an Outperform at SVB Leerink 03/03/21 Jefferies Gemini Therapeutics initiated with a Buy at Jefferies 03/02/21 Goldman Sachs Gemini Therapeutics initiated with a Buy at Goldman Sachs GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 02/09/21 Five new option listings and two option delistings on February 9th

Events

Earnings calls, analyst events, roadshows and more

INCY
Today at 08:30

Incyte - INCY Conference Calls
Today at 08:30

Technology;Media;Telecom Industry Meetings
APHA
Today at 09:00

Aphria - APHA Conference Calls
Today at 09:00

Infrastructure Industry Meetings
BBVA
Today at 09:00

European Banking/Financials Industry Meetings
ZLAB
Today at 10:00

Zai Lab - ZLAB Conference Calls
OTCM
Today at 10:00

OTC Markets Group Inc. Firm Sponsored Meetings

Virtual Meeting
Today at 10:00

Energy Industry Meetings
Today at 10:00

Retail/Softlines & Dept Stores Industry Meetings
CRDF
Today at 11:00

Cardiff Oncology - CRDF Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Dine Brands says Applebee's SSS improving roughly 8% QTD from January

TODAY'S FREE FLY STORIES

Get Full Fly Access